Evidence map›Paper›PMID 25975695›Full record

ArticleArthritis research & therapy2015

Evidence for cadherin-11 cleavage in the synovium and partial characterization of its mechanism.

Erika H Noss, Gerald F M Watts, Davide Zocco, Tracy L Keller, Malcolm Whitman, Carl P Blobel, David M Lee, Michael B Brenner

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Cadherin-11 as a regulator of valve myofibroblast mechanobiology.American journal of physiology. Heart and circulatory physiology · 2018
    Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Erika H NossDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard School of Medicine, Smith Research Building, 5th floor, 1 Jimmy Fund Way, Boston, MA, 02115, USA. enoss@partners.org.
Gerald F M WattsDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard School of Medicine, Smith Research Building, 5th floor, 1 Jimmy Fund Way, Boston, MA, 02115, USA. gwatts@rics.bwh.harvard.edu.
Davide ZoccoExosomics Siena S.p.A., Strada del Petriccio e Belriguardo, 35, 53100, Siena, Italy. dzocco@exosomics.eu.
Tracy L KellerHarvard School of Dental Medicine, Department of Developmental Biology, REB 505, 190 Longwood Avenue, Boston, MA, 02115, USA. tracy_keller@hms.harvard.edu.
Malcolm WhitmanHarvard School of Dental Medicine, Department of Developmental Biology, REB 505, 190 Longwood Avenue, Boston, MA, 02115, USA. mwhitman@hms.harvard.edu.
Carl P BlobelHospital for Special Surgery, 535 east 70th Street, New York, NY, 10021, USA. BlobelC@hss.edu.
David M LeeDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard School of Medicine, Smith Research Building, 5th floor, 1 Jimmy Fund Way, Boston, MA, 02115, USA. david_marvin.lee@roche.com.
Michael B BrennerDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard School of Medicine, Smith Research Building, 5th floor, 1 Jimmy Fund Way, Boston, MA, 02115, USA. mbrenner@research.bwh.harvard.edu.
Brigham and Women's Hospital · USHospital for Special Surgery · US

Funding

iRhoms 1 and 2: Key regulators of ADAM17-dependent EGFR signalingR01GM064750 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BLOBEL, CARL PETER · 2002 to 2019
$6.1M
Synovial Cadherin in Rheumatoid ArthritisR01AR048114 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B. · 2002 to 2012
$3.2M
Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5)R01CA170653 · NCI · GEORGETOWN UNIVERSITY · PI BYERS, STEPHEN W · 2012 to 2015
$2.4M
Regulation of synovial fibroblast function via Cadherin-11 cleavageR01AR057382 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B. · 2010 to 2014
$1.9M
MECHANISM OF ACTION OF HALOFUGINONE AS A NOVEL THERAPEUTICR01GM089885 · NIGMS · HARVARD MEDICAL SCHOOL · PI WHITMAN, MALCOLM R. · 2010 to 2013
$1.5M
Cadherin-11 growth factor receptor interactions in RA fibroblast hyperplasiaK08AR063696 · NIAMS · UNIVERSITY OF WASHINGTON · PI NOSS, ERIKA HEIDI · 2013 to 2017
$729k
NCI NIH HHS R01 CA170653NIAMS NIH HHS K08 AR063696NIAMS NIH HHS R01 AR048114NIAMS NIH HHS R01 AR057382NIGMS NIH HHS GM089885NIGMS NIH HHS R01 GM064750NIGMS NIH HHS R01 GM089885NIGMS NIH HHS R01 GM64750
6 · The paper itself

Abstract

introductionEngagement of the homotypic cell-to-cell adhesion molecule cadherin-11 on rheumatoid arthritis (RA) synovial fibroblasts with a chimeric molecule containing the cadherin-11 extracellular binding domain stimulated cytokine, chemokine, and matrix metalloproteinases (MMP) release, implicating cadherin-11 signaling in RA pathogenesis. The objective of this study was to determine if cadherin-11 extracellular domain fragments are found inside the joint and if a physiologic synovial fibroblast cleavage pathway releases those fragments.

methodsCadherin-11 cleavage fragments were detected by western blot in cell media or lysates. Cleavage was interrupted using chemical inhibitors or short-interfering RNA (siRNA) gene silencing. The amount of cadherin-11 fragments in synovial fluid was measured by western blot and ELISA.

resultsSoluble cadherin-11 extracellular fragments were detected in human synovial fluid at significantly higher levels in RA samples compared to osteoarthritis (OA) samples. A cadherin-11 N-terminal extracellular binding domain fragment was shed from synovial fibroblasts after ionomycin stimulation, followed by presenilin 1 (PSN1)-dependent regulated intramembrane proteolysis of the retained membrane-bound C-terminal fragments. In addition to ionomycin-induced calcium flux, tumor necrosis factor (TNF)-α also stimulated cleavage in both two- and three-dimensional fibroblast cultures. Although cadherin-11 extracellular domains were shed by a disintegrin and metalloproteinase (ADAM) 10 in several cell types, a novel ADAM- and metalloproteinase-independent activity mediated shedding in primary human fibroblasts.

conclusionsCadherin-11 undergoes ectodomain shedding followed by regulated intramembrane proteolysis in synovial fibroblasts, triggered by a novel sheddase that generates extracelluar cadherin-11 fragments. Cadherin-11 fragments were enriched in RA synovial fluid, suggesting they may be a marker of synovial burden and may function to modify cadherin-11 interactions between synovial fibroblasts.

Indexed as

Arthritis, RheumatoidBlotting, WesternCadherinsCells, CulturedEnzyme-Linked Immunosorbent AssayFibroblastsHumansImmunoprecipitationOsteoarthritisPeptide FragmentsRNA, Small InterferingSynovial FluidSynovial MembraneTransfectionCadherinsosteoblast cadherinPeptide FragmentsRNA, Small Interfering

Identifiers

PMID25975695
PMCPMC4449585
OpenAlexW2114912627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.